D-0157-2026 Class III Ongoing

Recalled by Imprimis NJOF, LLC — Ledgewood, NJ

FDA drug recall D-0157-2026 was initiated by Imprimis NJOF, LLC on Oct 20, 2025 and is designated Class III. Reason for recall: Subpotent Drug The recall status is ongoing. Affected quantity: 67,091 bottles.

Recall details

Product Type
Drugs
Report Date
Nov 26, 2025
Initiation Date
Oct 20, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
67,091 bottles

Product description

Klarity-C Drops (Cyclosporine) 0.1%, Preservative-Free Sterile Ophthalmic Emulsion, This is a compounded drug, Office Use Only, 5.5 mL bottle, Rx only, Mfg by: Imprimis NJOF, LLC, 1705 Route 46 West, Ledgewood, NJ 07852, NDC 71384-514-05

Reason for recall

Subpotent Drug

Distribution pattern

USA nationwide

Code information

Lot #:25JAN029, exp. date 07Nov2025; 25JAN042, exp. date 14Nov2025; 25JAN054, exp. date 21Nov2025; 25MAR021, exp. date 07Dec2025; 25APR017, exp. date 04Jan2026, 25APR025, exp. date 05Jan2026; 25MAY032, exp. date 31Jan2026; 25MAY055, exp. date 12Mar2026; 25MAY057, exp. date 14Mar2026; 25MAY073, exp. date 21Mar2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0157-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0157-2026. Report a data issue: hello@regdatalab.com.